| Nome |
# |
|
Convexal subarachnoid hemorrhage and acute ischemic stroke: a border zone matter?, file dd9e0c69-f009-1e9c-e053-3a05fe0a45ef
|
231
|
|
Multiparametric unconventional MRI study in early stage of ALS disease, file dd9e0c6a-af49-1e9c-e053-3a05fe0a45ef
|
231
|
|
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia, file dd9e0c6a-7fe7-1e9c-e053-3a05fe0a45ef
|
213
|
|
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis, file dd9e0c67-f18b-1e9c-e053-3a05fe0a45ef
|
182
|
|
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis, file dd9e0c68-e24e-1e9c-e053-3a05fe0a45ef
|
143
|
|
Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral
Sclerosis, file dd9e0c68-195d-1e9c-e053-3a05fe0a45ef
|
129
|
|
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study, file dd9e0c65-0da8-1e9c-e053-3a05fe0a45ef
|
110
|
|
Pediatric multiple sclerosis: Clinical features and outcome, file dd9e0c63-b540-1e9c-e053-3a05fe0a45ef
|
109
|
|
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis, file dd9e0c6a-7e23-1e9c-e053-3a05fe0a45ef
|
88
|
|
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG., file dd9e0c67-d029-1e9c-e053-3a05fe0a45ef
|
65
|
|
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis, file dd9e0c67-d030-1e9c-e053-3a05fe0a45ef
|
50
|
|
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled,multicentre clinical trial for colchicine in ALS (Co-ALS), file dd9e0c68-0f9a-1e9c-e053-3a05fe0a45ef
|
50
|
|
The role of imaging in Hirayama disease, file dd9e0c63-b2a8-1e9c-e053-3a05fe0a45ef
|
49
|
|
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial), file dd9e0c67-d03e-1e9c-e053-3a05fe0a45ef
|
49
|
|
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study, file dd9e0c65-0daa-1e9c-e053-3a05fe0a45ef
|
48
|
|
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B, file dd9e0c64-43d9-1e9c-e053-3a05fe0a45ef
|
45
|
|
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis., file dd9e0c6a-c550-1e9c-e053-3a05fe0a45ef
|
45
|
|
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene, file dd9e0c6a-93bd-1e9c-e053-3a05fe0a45ef
|
44
|
|
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients, file dd9e0c63-bc3a-1e9c-e053-3a05fe0a45ef
|
41
|
|
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study., file dd9e0c67-f198-1e9c-e053-3a05fe0a45ef
|
38
|
|
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients, file d870cf6d-c6da-43ff-8dad-f183c76b5929
|
23
|
|
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene, file a49ad681-2ce9-4203-b916-bde9ab8cf970
|
10
|
|
The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis, file dd9e0c68-d05e-1e9c-e053-3a05fe0a45ef
|
7
|
|
A 71-nucleotide deletion in the periaxin gene in an Italian patient with late-onset slowly progressive demyelinating CMT, file dd9e0c68-e46a-1e9c-e053-3a05fe0a45ef
|
6
|
|
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients, file dd9e0c69-ea74-1e9c-e053-3a05fe0a45ef
|
6
|
|
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis, file dd9e0c68-a367-1e9c-e053-3a05fe0a45ef
|
5
|
|
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study, file dd9e0c63-b578-1e9c-e053-3a05fe0a45ef
|
4
|
|
null, file dd9e0c63-b6db-1e9c-e053-3a05fe0a45ef
|
4
|
|
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes, file dd9e0c68-d05c-1e9c-e053-3a05fe0a45ef
|
4
|
|
Localized 1H-MR spectroscopy for metabolic characterization of brain diffuse and focal lesions in HIV infected patients, file dd9e0c63-b2e4-1e9c-e053-3a05fe0a45ef
|
3
|
|
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience, file dd9e0c6b-54e8-1e9c-e053-3a05fe0a45ef
|
3
|
|
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients?, file dd9e0c6b-6bf6-1e9c-e053-3a05fe0a45ef
|
3
|
|
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis.
AJNR Am J Neuroradiol. 2007 Feb;28(2):255-9, file dd9e0c62-6a9d-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c62-80e9-1e9c-e053-3a05fe0a45ef
|
2
|
|
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances, file dd9e0c63-b2ac-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c63-b2b2-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c63-b39b-1e9c-e053-3a05fe0a45ef
|
2
|
|
Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis., file dd9e0c63-b489-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c63-b6ae-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c63-ba5c-1e9c-e053-3a05fe0a45ef
|
2
|
|
Life-threatening ADEM in an immunocompetent pregnant woman with concomitant asymptomatic Cytomegalovirus infection, file dd9e0c63-ba8b-1e9c-e053-3a05fe0a45ef
|
2
|
|
TBK1 is associated with ALS and ALS-FTD in Sardinian patients, file dd9e0c63-bb7e-1e9c-e053-3a05fe0a45ef
|
2
|
|
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study, file dd9e0c63-bd59-1e9c-e053-3a05fe0a45ef
|
2
|
|
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion, file dd9e0c63-bdd4-1e9c-e053-3a05fe0a45ef
|
2
|
|
MR evaluation of encephalic leukoaraiosis in sudden sensorineural hearing loss (SSNHL) patients, file dd9e0c65-69e5-1e9c-e053-3a05fe0a45ef
|
2
|
|
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement, file dd9e0c66-594d-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c67-9274-1e9c-e053-3a05fe0a45ef
|
2
|
|
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy, file dd9e0c67-e244-1e9c-e053-3a05fe0a45ef
|
2
|
|
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial), file dd9e0c68-12b4-1e9c-e053-3a05fe0a45ef
|
2
|
|
Assisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program, file dd9e0c68-3ae1-1e9c-e053-3a05fe0a45ef
|
2
|
|
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy, file dd9e0c68-d061-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c62-6127-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c62-733c-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c62-7896-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c62-79ce-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c62-7e05-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c62-8125-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-15a4-1e9c-e053-3a05fe0a45ef
|
1
|
|
HFE p.H63D polymorphism does not influence ALS phenotype and survival, file dd9e0c63-b27d-1e9c-e053-3a05fe0a45ef
|
1
|
|
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry, file dd9e0c63-b283-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-b2e7-1e9c-e053-3a05fe0a45ef
|
1
|
|
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids, file dd9e0c63-b32d-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-b40a-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-b6e1-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-b760-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-ba54-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-ba60-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-ba88-1e9c-e053-3a05fe0a45ef
|
1
|
|
Long term results of immunomodulatory treatment in children and adolescents with multiple
sclerosis: the Italian experience, file dd9e0c63-bb0a-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-bb0d-1e9c-e053-3a05fe0a45ef
|
1
|
|
Hirayama disease: the importance of an early diagnosis, file dd9e0c63-bb42-1e9c-e053-3a05fe0a45ef
|
1
|
|
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis, file dd9e0c63-bc3d-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-bc6f-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c66-2666-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c67-7455-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c67-7d56-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c67-7f2d-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c67-8da6-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c67-b99f-1e9c-e053-3a05fe0a45ef
|
1
|
|
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis, file dd9e0c67-d03b-1e9c-e053-3a05fe0a45ef
|
1
|
|
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP)., file dd9e0c67-e8a3-1e9c-e053-3a05fe0a45ef
|
1
|
| Totale |
2.106 |